Company Team Search Site Map Careers Privacy Statement
:: Home
:: About Us
:: R&D
:: Products
:: Services
:: Infrastucture
:: Contact us
Virchow Products
Overview

For more than 27 years, Virchow group has focused itself on the development of innovative processes and cost effective backward integration. The company's emphasis on economic research combined with an applied focus on unmet medical needs has been instrumental in its success and growth. The company also fosters individual creativity and initiative among its researchers, encouraging scientists to pursue projects. As a result, our scientists have consistently published important papers in prestigious peer-reviewed journals.

News & Events

Virchow Biotech is filing for U.S.Food and Drug administration’s (FDA) approval for its in house developed advanced wound care products.

Virchow Biotech received Drug control’s (DCGI) approval for conducting clinical trials on periogen, an indigenously developed recombinant therapeutic product for periodontal diseases

Virchow Biotech and Ranbaxy signed an MOU to market Virchow’s indigenously developed recombinant therapeutic protein for osteoporosis treatment. We are the first in the world to launch this biogeneric product